These outcomes, together with a prior report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,two support the thought of focusing on ACKR3 as a novel way to modulate the opioid system, which could open new therapeutic avenues for opioid-linked disorders. Conolidine statements to become a https://abbac395vdk0.blogrelation.com/profile